The cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis in Canada. Su W, Kansal A, Vicente C, Deniz B, Sarda S J Med Econ. 2016 Apr 15:1-10. PMID: 27080475. Abstract CommentRecommendBookmarkWatch